Related references
Note: Only part of the references are listed.Mavacamten Treatment for Obstructive Hypertrophic Cardiomyopathy A Clinical Trial
Stephen B. Heitner et al.
ANNALS OF INTERNAL MEDICINE (2019)
Feline Hypertrophic Cardiomyopathy: A Spontaneous Large Animal Model of Human HCM
Lisa M. Freeman et al.
CARDIOLOGY RESEARCH (2017)
Hypertrophic Cardiomyopathy Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy
Ali J. Marian et al.
CIRCULATION RESEARCH (2017)
Calcium Signaling and Cardiac Arrhythmias
Andrew P. Landstrom et al.
CIRCULATION RESEARCH (2017)
Myocardial energy depletion and dynamic systolic dysfunction in hypertrophic cardiomyopathy
Julian O. M. Ormerod et al.
NATURE REVIEWS CARDIOLOGY (2016)
A small-molecule inhibitor of sarcomere contractility suppresses hypertrophic cardiomyopathy in mice
Eric M. Green et al.
SCIENCE (2016)
Hypertrophic Cardiomyopathy Registry: The rationale and design of an international, observational study of hypertrophic cardiomyopathy
Christopher M. Kramer et al.
AMERICAN HEART JOURNAL (2015)
New Perspectives on the Prevalence of Hypertrophic Cardiomyopathy
Christopher Semsarian et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Cardiac Titin and Heart Disease
Martin M. LeWinter et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2014)
Clinical Phenotype and Outcome of Hypertrophic Cardiomyopathy Associated With Thin-Filament Gene Mutations
Raffaele Coppini et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Hypertrophic Cardiomyopathy Present and Future, With Translation Into Contemporary Cardiovascular Medicine
Barry J. Maron et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Small and large animal models in cardiac contraction research: Advantages and disadvantages
Nima Milani-Nejad et al.
PHARMACOLOGY & THERAPEUTICS (2014)
Search for supersymmetry in pp collisions at √s=7 TeV in events with a single lepton, jets, and missing transverse momentum
S. Chatrchyan et al.
EUROPEAN PHYSICAL JOURNAL C (2013)
Animal Models of GWAS-Identified Type 2 Diabetes Genes
Gabriela da Silva Xavier et al.
JOURNAL OF DIABETES RESEARCH (2013)
In Vivo Cardiac Myosin Binding Protein C Gene Transfer Rescues Myofilament Contractile Dysfunction in Cardiac Myosin Binding Protein C Null Mice
Sergei Merkulov et al.
CIRCULATION-HEART FAILURE (2012)
Generation and Functional Characterization of Knock-in Mice Harboring the Cardiac Troponin I-R21C Mutation Associated with Hypertrophic Cardiomyopathy
Yingcai Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Hypertrophic cardiomyopathy: Translating cellular cross talk into therapeutics
Polakit Teekakirikul et al.
JOURNAL OF CELL BIOLOGY (2012)
PROGNOSTIC UTILITY OF CONTRAST-ENHANCED CARDIOVASCULAR MAGNETIC RESONANCE IN HYPERTROPHIC CARDIOMYOPATHY: AN INTERNATIONAL MULTICENTER STUDY
Raymond H. Chan et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Genetics of Hypertrophic Cardiomyopathy After 20 Years Clinical Perspectives
Barry J. Maron et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Clinical Utility of Cardiovascular Magnetic Resonance in Hypertrophic Cardiomyopathy
Martin S. Maron
JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE (2012)
Structural and functional aspects of the myosin essential light chain in cardiac muscle contraction
Priya Muthu et al.
FASEB JOURNAL (2011)
The Role of MEKK1 in Hypertrophic Cardiomyopathy
John P. Konhilas et al.
INTERNATIONAL HEART JOURNAL (2010)
Cardiac fibrosis in mice with hypertrophic cardiomyopathy is mediated by non-myocyte proliferation and requires Tgf-β
Polakit Teekakirikul et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Neonatal gene transfer of Serca2a delays onset of hypertrophic remodeling and improves function in familial hypertrophic cardiomyopathy
James R. Pena et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2010)
Prognostic Significance of Myocardial Fibrosis in Hypertrophic Cardiomyopathy
Rory O'Hanlon et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Heterogeneous myocyte enhancer factor-2 (Mef2) activation in myocytes predicts focal scarring in hypertrophic cardiomyopathy
Tetsuo Konno et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Diastolic dysfunction in familial hypertrophic cardiomyopathy transgenic model mice
Theodore P. Abraham et al.
CARDIOVASCULAR RESEARCH (2009)
Truncation of Titin's Elastic PEVK Region Leads to Cardiomyopathy With Diastolic Dysfunction
Henk L. Granzier et al.
CIRCULATION RESEARCH (2009)
Malignant familial hypertrophic cardiomyopathy D166V mutation in the ventricular myosin regulatory light chain causes profound effects in skinned and intact papillary muscle fibers from transgenic mice
W. Glenn L. Kerrick et al.
FASEB JOURNAL (2009)
The Case for Myocardial Ischemia in Hypertrophic Cardiomyopathy
Martin S. Maron et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Cardiac fibroblasts: At the heart of myocardial remodeling
Karen E. Porter et al.
PHARMACOLOGY & THERAPEUTICS (2009)
Severe heart failure and early mortality in a double-mutation mouse model of familial hypertrophic cardiomyopathy
Tatiana Tsoutsman et al.
CIRCULATION (2008)
An FHL1-containing complex within the cardiomyocyte sarcomere mediates hypertrophic biomechanical stress responses in mice
Farah Sheikh et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
The MEF2D transcription factor mediates stress-dependent cardiac remodeling in mice
Yuri Kim et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy on relation to delayed enhancement on cardiovascular magnetic resonance
A. Selcuk Adabag et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
A substitution mutation in the myosin binding protein C gene in ragdoll hypertrophic cardiomyopathy
Kathryn M. Meurs et al.
GENOMICS (2007)
Combined effects of low-dose spironolactone and captopril therapy in a rat model of genetic hypertrophic cardiomyopathy
Micheline Monteiro de Resende et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2006)
Molecular insights from a novel cardiac troponin I mouse model of familial hypertrophic cardiomyopathy
Tatiana Tsoutsman et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2006)
Robust systemic transduction with AAV9 vectors in mice: Efficient global cardiac gene transfer superior to that of AAV8
Katsuya Inagaki et al.
MOLECULAR THERAPY (2006)
Diltiazem treatment prevents diastolic heart failure in mice with familial hypertrophic cardiomyopathy
D Westermann et al.
EUROPEAN JOURNAL OF HEART FAILURE (2006)
A cardiac myosin binding protein C mutation in the Maine Coon cat with familial hypertrophic cardiomyopathy
KM Meurs et al.
HUMAN MOLECULAR GENETICS (2005)
Compound and double mutations in patients with hypertrophic cardiomyopathy: implications for genetic testing and counselling
J Ingles et al.
JOURNAL OF MEDICAL GENETICS (2005)
The E22K mutation of myosin RLC that causes familial hypertrophic cardiomyopathy increases calcium sensitivity of force and ATPase in transgenic mice
D Szczesna-Cordary et al.
JOURNAL OF CELL SCIENCE (2005)
Transgenic rabbit model for human troponin I - Based hypertrophic cardiomyopathy
A Sanbe et al.
CIRCULATION (2005)
Myosin binding protein C: Structural abnormalities in familial hypertrophic cardiomyopathy
CE Oakley et al.
CELL RESEARCH (2004)
Frequency and clinical expression of cardiac troponin I mutations in 748 consecutive families with hypertrophic cardiomyopathy
J Mogensen et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy
SL Van Driest et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
Prevalence and spectrum of thin filament mutations in an outpatient referral population with hypertrophic cardiomyopathy
SL Van Driest et al.
CIRCULATION (2003)
Phenotypic diversity in hypertrophic cardiomyopathy
M Arad et al.
HUMAN MOLECULAR GENETICS (2002)
Cardiac-specific activation of signal transducer and activator of transcription 3 promotes vascular formation in the heart
T Osugi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
A familial hypertrophic cardiomyopathy α-tropomyosin mutation causes severe cardiac hypertrophy and death in mice
R Prabhakar et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2001)
Inotropic stimulation induces cardiac dysfunction in transgenic mice expressing a troponin T (I79N) mutation linked to familial hypertrophic cardiomyopathy
BC Knollmann et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Abnormal contractile function in transgenic mice expressing a familial hypeptrophic cardiomyopathy-linked troponin T (I79N) mutation
T Miller et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Phospholamban and cardiac contractile function
AG Brittsan et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2000)
Transgenic rat hearts expressing a human cardiac troponin T deletion reveal diastolic dysfunction and ventricular arrhythmias
N Frey et al.
CARDIOVASCULAR RESEARCH (2000)
Animal models of hypertrophic cardiomyopathy
AH Maass et al.
CURRENT OPINION IN CARDIOLOGY (2000)
Morphology and significance of the left ventricular collagen network in young patients with hypertrophic cardiomyopathy and sudden cardiac death
J Shirani et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2000)